💊FDA Issues Regulatory Review Period for VOWST Patent Extension
The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for VOWST and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of applications to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human biological product.
Learn More📊Proposed Data Collection for Youth Tobacco Survey by CDC
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled National Youth Tobacco Survey (NYTS) 2024-2026. NYTS provides national estimates of tobacco use behaviors, information about exposure to pro- and anti-tobacco influences, and information about racial and ethnic disparities in tobacco-related topics is the most comprehensive source of nationally representative tobacco data among students in grades 9-12, and is the only source of data for students in grades 6-8.
Learn More💊FDA Notice on Regulatory Review Period for XOLREMDI Patent Extension
The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for XOLREMDI and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of applications to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human drug product.
Learn More💊FDA Determination of Regulatory Review Period for ZEVTERA Patent Extension
The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for ZEVTERA and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human drug product.
Learn More📊Public Comment on National Science Foundation Data Access Renewal
The National Center for Science and Engineering Statistics (NCSES) within the National Science Foundation (NSF), as the Standard Application Process (SAP) Program Management Office designated by the Office of Management and Budget (OMB), is seeking approval to renew the SAP Portal information collection as a Common Form, OMB control number 3145-0271, to permit other federal agency users to streamline the information collection in coordination with OMB. The purpose of this notice is to allow for 60 days of public comment on the proposed SAP Portal information collection as a Common Form, prior to the submission of the information collection request (ICR) to OMB for approval. In accordance with the requirements of the Paperwork Reduction Act of 1995, NCSES is providing opportunity for public comment on this action. After obtaining and considering public comment, NCSES will prepare the submission requesting that OMB renew this information collection for three years.
Learn More✈️FAA Proposes New Airworthiness Directive for Boeing Aircraft
The FAA proposes to supersede Airworthiness Directive (AD) 2013-08-11, which applies to certain The Boeing Company Model 737-900 and -900ER series airplanes. AD 2013-08-11 requires repetitive inspections for cracking of the fuselage skin along chem-mill steps at certain crown skin and shear wrinkle areas and repair if necessary. Since the FAA issued AD 2013-08-11, the FAA has determined that the compliance times are not adequate. This proposed AD would continue to require the actions in AD 2013-08-11 but at reduced compliance times and would require post-modification inspections if an optional modification is accomplished. The FAA is proposing this AD to address the unsafe condition on these products.
Learn More⚖️Notice on Repatriation under NAGPRA by U.S. Department of Interior
In accordance with the Native American Graves Protection and Repatriation Act (NAGPRA), the U.S. Department of the Interior, Bureau of Land Management, Oregon/Washington State Office, Lakeview District Office (BLM Lakeview District Office) has completed an inventory of human remains and associated funerary objects and has determined that there is a cultural affiliation between the human remains and associated funerary objects and Indian Tribes or Native Hawaiian organizations in this notice.
Learn More🚨FDA Notice on Information Collection for Medical Devices Regulation
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Learn More📦Final Antidumping Duty Review Results for Ripe Olives from Spain
The U.S. Department of Commerce (Commerce) determines that certain producers/exporters subject to this administrative review made sales of subject merchandise at less than normal value during the period of review (POR) August 1, 2022, through July 31, 2023.
Learn More⚡Business Implications of Combined Notice of Filings by FERC
The notice from the Department of Energy highlights numerous electric corporate filings, covering joint applications, complaints, rate changes, and security filings under the Federal Power Act. These filings detail the interactions and potential regulatory changes affecting electric utilities, which business owners and executives must closely monitor for compliance and financial impact.
Learn More